← SynDRA
AT-13148
SynDRA canonical compound SYN0038179 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AKT1 | AKT2 | AKT3 | ROCK1 | ROCK2 | SGK3 |
|---|
| Mechanism of action | protein kinase inhibitor |
|---|
All known targets
- ROCK1
- ROCK2
- AKT1
- AKT2
- AKT3
- MAPKAPK2
- SGK3
Mechanisms of action (all sources)
- ROCK2 INHIBITOR
- Rho-associated protein kinase inhibitor
- ROCK1 INHIBITOR
- MAPKAPK2 INHIBITOR
- MAP kinase-activated protein kinase 2 inhibitor
- protein kinase inhibitor
Cross-references
Synonyms
- AT13148
- A49037RP1E
- RefChem:916440
- Multi-AGC Kinase Inhibitor AT13148
- UNII-A49037RP1E
- MFCD25976789
- RKD
- SCHEMBL851471
- orb1305420
- GLXC-04834
- EX-A1797
- BDBM50242733
- NSC771650
- NSC799337
- s7563
- AKOS024258899
- CCG-267617
- CS-3136
- EBC-157201
- NSC-771650
- NSC-799337
- SB16880
- NCGC00386423-03
- NCGC00386423-04
- AC-32943
- AS-35164
- FA137648
- HY-16071
- F459624
- BRD-K32127727-001-01-8
- BRD-K32127727-001-02-6
- Z2685929061
Look up AT-13148 in the interactive SynDRA portal →